KEY FINDINGS
The global sleep apnea therapeutics and diagnostics market is anticipated to grow at a CAGR of 6.78% during the forecast period, 2021-2028. The increasing sleep apnea incidences, rising geriatric population, growing obesity, technological advancements, etc., propel market growth.
MARKET INSIGHTS
Sleep apnea is a sleep disorder wherein the patient's breathing patterns stop or decrease during sleep. The pause can last 10 seconds or longer. It can also occur up to 30 times in an hour. Loud snoring, restless sleep, and daytime sleepiness are the symptoms of sleep apnea. Since the 1990s, the prevalence of sleep apnea has been increasing significantly. Though the diagnosis rate is very low. For instance, as per the Canadian Medical Association Journal (CMAJ) study of December 2017, around 3%-50% of adults had sleep apnea. Out of which, only 3% had the disease clinically diagnosed. Undiagnosed sleep apnea can lead to chronic conditions like depression, cognitive impairment, metabolic disorders, and cardiovascular diseases. Also, sleep apnea can aggravate the risk of motor accidents and mortality rates.
Furthermore, several regional associations like the Indian Association of Surgeons for Sleep Apnea, Canadian Sleep Society, and America Sleep Apnea Association (ASAA) spread awareness about sleep apnea. Further, organizations are encouraging research in sleep medicines and conducting seminars for bringing the patient and physicians on the same platform. Moreover, the increasing awareness about the ill effects of untreated sleep apnea has raised the adoption of sleep apnea devices like Actigraphy devices, sleep testing devices, portable treatment devices, etc. Such factors drive market growth.
REGIONAL INSIGHTS
The global sleep apnea therapeutics and diagnostics market growth evaluation includes the analysis of North America, Asia-Pacific, Europe, and Rest of World. Government initiatives and technological advancements contribute to the market prospects of North America. It is the dominating region in the global market with the highest revenue.
COMPETITIVE INSIGHTS
The moderately intense rivalry in the market includes new entrants and local players putting pressure on the existing players. Some of the prominent companies in the market include BMC Medical Co Ltd, Invacare Corporation, Itamar Medical Ltd, GE Healthcare, Braebon Medical Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION AND OBESITY
3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
3.1.3. SLEEP APNEA INCIDENCES
3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SLEEP APNEA DEVICES
3.2.2. LACK OF REIMBURSEMENTS
3.2.3. DEARTH OF PATIENT COMPLIANCE
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. REGULATORY FRAMEWORK
4.4.1. NORTH AMERICA
4.4.2. EUROPE
4.4.3. ASIA-PACIFIC
4.5. SUPPLY CHAIN ANALYSIS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY PRODUCT TYPE
5.1. THERAPEUTICS
5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
5.1.1.1. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
5.1.1.2. BILEVEL POSITIVE AIRWAY PRESSURE (BPAP) DEVICES
5.1.2. OXYGEN DEVICES
5.1.2.1. OXYGEN CONCENTRATORS
5.1.2.2. PORTABLE OXYGEN CONCENTRATORS
5.1.2.3. LIQUID PORTABLE OXYGEN
5.1.3. MASKS AND ACCESSORIES
5.1.4. ORAL APPLIANCES
5.1.4.1. MANDIBULAR ADVANCEMENT DEVICES
5.1.4.2. TONGUE RETAINERS
5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
5.2. DIAGNOSTICS AND MONITORING
5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
5.2.1.1. CLINICAL PSG DEVICE
5.2.1.2. AMBULATORY PSG DEVICE
5.2.2. OXIMETER
5.2.2.1. TABLETOP OXIMETER
5.2.2.2. FINGERTIP OXIMETER
5.2.2.3. HANDHELD OXIMETER
5.2.2.4. WRIST-WORN OXIMETER
5.2.3. ACTIGRAPHY MONITORING DEVICE
5.2.4. RESPIRATORY POLYGRAPH
5.2.5. SLEEP APNEA SCREENING DEVICE
5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES
6. MARKET BY END-USER
6.1. HOSPITALS & SLEEP LABORATORIES
6.2. HOME CARE SETTINGS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. KEY GROWTH ENABLERS
7.2.3. KEY CHALLENGES
7.2.4. KEY PLAYERS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. BELGIUM
7.2.5.7. POLAND
7.2.5.8. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. KEY GROWTH ENABLERS
7.3.3. KEY CHALLENGES
7.3.4. KEY PLAYERS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. AUSTRALIA & NEW ZEALAND
7.3.5.4. INDIA
7.3.5.5. SOUTH KOREA
7.3.5.6. THAILAND
7.3.5.7. INDONESIA
7.3.5.8. VIETNAM
7.3.5.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. KEY GROWTH ENABLERS
7.4.3. KEY CHALLENGE
7.4.4. KEY PLAYERS
7.4.5. REGIONAL ANALYSIS
7.4.5.1. LATIN AMERICA
7.4.5.2. MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BMC MEDICAL CO LTD
8.2.2. BRAEBON MEDICAL CORPORATION
8.2.3. CADWELL INDUSTRIES INC
8.2.4. DEVILBISS HEALTHCARE LLC
8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
8.2.6. GE HEALTHCARE
8.2.7. INVACARE CORPORATION
8.2.8. ITAMAR MEDICAL LTD
8.2.9. KONINKLIJKE PHILIPS NV
8.2.10. MEDTRONIC PLC
8.2.11. NIHON KOHDEN CORPORATION
8.2.12. RESMED INC
8.2.13. SMITHS MEDICAL INC
8.2.14. SOMNOMEDICS GMBH
8.2.15. TELEFLEX INCORPORATED
8.2.16. VYAIRE MEDICAL INC
1. BMC MEDICAL CO LTD
2. BRAEBON MEDICAL CORPORATION
3. CADWELL INDUSTRIES INC
4. DEVILBISS HEALTHCARE LLC
5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
6. GE HEALTHCARE
7. INVACARE CORPORATION
8. ITAMAR MEDICAL LTD
9. KONINKLIJKE PHILIPS NV
10. MEDTRONIC PLC
11. NIHON KOHDEN CORPORATION
12. RESMED INC
13. SMITHS MEDICAL INC
14. SOMNOMEDICS GMBH
15. TELEFLEX INCORPORATED
16. VYAIRE MEDICAL INC
